102
Views
3
CrossRef citations to date
0
Altmetric
Clinical Trial Report

A Randomized Double-Blind Placebo-Control Feasibility Trial of Immunoglobulin Treatment for Prevention of Recurrent Acute Exacerbations of COPD

ORCID Icon, ORCID Icon, , ORCID Icon, , , , , , , , , , , & show all
Pages 3275-3284 | Published online: 03 Dec 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Miguel Angel Martinez-Garcia & Marc Miravitlles. (2022) The Impact of Chronic Bronchial Infection in COPD: A Proposal for Management. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 621-630.
Read now

Articles from other publishers (2)

Anna Vanoverschelde, Samer R. Khan, Virgil A.S.H. Dalm, Layal Chaker, Guy Brusselle, Bruno H. Stricker & Lies Lahousse. (2023) Serum immunoglobulin levels and risk of antibiotic prescription in middle-aged and older individuals: A population-based cohort study. Clinical Immunology Communications 4, pages 23-29.
Crossref
Leif G. Hanitsch. (2022) Bronchiectasis and obstructive lung diseases in primary antibody deficiencies and beyond: update on management and pathomechanisms. Current Opinion in Allergy & Clinical Immunology 22:6, pages 335-342.
Crossref